Alpha/Beta T and B Cell Depletion With Zoledronic Acid for Solid Tumors

Recruiting

Phase 1

Phase 2

αβ-T Cell Depletion with Zoledronic AcidAlpha/Beta T and B Cell Depletion With Zoledronic Acid for Solid Tumors

Sponsor:

University of Florida

Code:

NCT06625190

Conditions

Neuroblastoma

Rhabdomyosarcoma

Synovial Sarcoma

Peripheral Nerve Sheath Tumors

Clear Cell Sarcoma

Eligibility Criteria

Sex: All

Age: 0 - 25

Healthy Volunteers: Not accepted

Interventions

Miltenyi CliniMACS Prodigy ® system

Zoledronic acid

Study Details

Eligibility Criteria

Study Design

Interventions and Outcome Measures

Central Contacts and Locations

More Information

Trial information was received from ClinicalTrials.gov and was last updated on 2026-02-13. This information was provided to ClinicalTrials.gov by University of Florida on 2025-12-17.